Recent Updates
Recently added Catalysts
ECOR Positive Sentiment Score: 75/100

electroCore to Participate in Upcoming Investor Conferences

Key Takeaway: electroCore, Inc. announced its participation in two upcoming investor conferences. Chief Strategy Officer Joshua Lev will attend the 36th Annual Roth Conference from March 17-19, 2024, with 1x1 meetings hosted on March 18 and 19. CEO Dan Goldberger will present at the 23rd Annual Needham Virtual Healthcare Conference from April 8-11, 2024, also hosting one-on-one meetings. These events highlight the company's commitment to engaging with investors and promoting its bioelectronic medicine technology.

Market Sentiment Analysis

POSITIVE FACTORS

  • electroCore's participation in prominent investor conferences indicates strong interest and engagement with investors.
  • The company is actively promoting its unique nVNS technology platform, showcasing its commitment to advancing bioelectronic medicine.
  • Scheduled 1x1 investor meetings offer personalized interactions, which can enhance investor relations.

Full Press Release Details

ROCKAWAY, N.J., March 12, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that the Company’s Chief Strategy Officer, Joshua Lev, is scheduled to attend the 36th Annual Roth Conference taking place at The Ritz Carlton Laguna Niguel in Dana Point, California on March 17 – 19, 2024. electroCore will host 1x1 investor meetings on March 18 and 19, 2024. Please contact Roth MKM to schedule a 1x1 meeting.
In addition, Dan Goldberger, CEO of electroCore, Inc. is scheduled to participate in the 23rd Annual Needham Virtual Healthcare Conference on April 8 – 11, 2024. Mr. Goldberger will give a company presentation on April 8th at 3:00 pm and will host 1x1 investor meetings throughout the conference. Please contact Needham to schedule a 1x1 meeting.
About electroCore, Inc.
electroCore, Inc. is a commercial stage bioelectronic medicine and wellness company dedicated to improving health through its non-invasive vagus nerve stimulation (“nVNS”) technology platform. Our focus is the commercialization of medical devices for the management and treatment of certain medical conditions and consumer product offerings utilizing nVNS to promote general wellbeing and human performance in the United States and select overseas markets.
For more information, visit www.electrocore.com.
ECOR Investor Relations

Tags

Frequently Asked Questions

What event will electroCore attend in March 2024?

electroCore will attend the 36th Annual Roth Conference from March 17-19, 2024.

When is electroCore's presentation at the Needham Conference?

electroCore's CEO will present on April 8, 2024, at 3:00 pm.

What technology does electroCore focus on?

electroCore specializes in non-invasive vagus nerve stimulation technology.

How can investors schedule meetings with electroCore executives?

Investors can contact Roth MKM or Needham to schedule 1x1 meetings.

Last updated: Mar 12, 2024